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Abstract
Nitric oxide (NO) activates the intrinsic apoptotic pathway to induce cell death. However, the mechanism by which this
pathway is activated in cells exposed to NO is not known. Here we report that BAX and BAK are activated by NO and that
cytochrome c is released from the mitochondria. Cells deficient in Bax and Bak or Caspase-9 are completely protected from
NO-induced cell death. The individual loss of the BH3-only proteins, Bim, Bid, Puma, Bad or Noxa,o rBid knockdown in Bim
2/2/
Puma
2/2 MEFs, does not prevent NO-induced cell death. Our data show that the anti-apoptotic protein MCL-1 undergoes
ASK1-JNK1 mediated degradation upon exposure to NO, and that cells deficient in either Ask1 or Jnk1 are protected against
NO-induced cell death. NO can inhibit the mitochondrial electron transport chain resulting in an increase in superoxide
generation and peroxynitrite formation. However, scavengers of ROS or peroxynitrite do not prevent NO-induced cell death.
Collectively, these data indicate that NO degrades MCL-1 through the ASK1-JNK1 axis to induce BAX/BAK-dependent cell
death.
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Introduction
Nitric oxide (NO) has been shown to have both protective and
deleterious functions. This molecule is critical for multiple
physiological functions, yet plays a role in many pathological states,
including neurodegenerative disease and cancer. A major target of
NO is cytochrome oxidase (COX), the terminal enzyme of the
electron transport chain (ETC) [1–3]. NO binds COX reversibly to
regulate cellular respiration. Although NO’s ability to modify
biological molecules has proven to be physiologically important,
NO-dependent modifications may contribute to cell death through
S-nitrosylation of proteins or the formation of peroxynitrite.
Prolonged exposure to NO inhibits complex I of the ETC likely
through S-nitrosylation[4]. Inhibitionof complex I by NO has been
hypothesized to result in an elevated release of oxidants from the
ETC [5]. An increase in oxidants in the presence of NO favors the
formation of the highly reactive molecule peroxynitrite which can
activate p38 and c-Jun N-terminal kinase (JNK) to initiate the
intrinsic apoptotic pathway [6–8].
The BCL-2 family of proteins regulate the intrinsic apoptotic
pathway. These proteins can be divided into two subclasses, the
anti-apoptotic proteins (BCL-2, BCL-XL, BCL-w, MCL-1 and A1),
and the pro-apoptotic proteins which include the multi-domain
BCL-2 proteins (BAX, BAK and BOK) and the BH3-only proteins
(including BIM, BID, PUMA, BAD and NOXA). In healthy cells,
BAX and BAK exist as monomers in the cytosol and at the
mitochondrial outer membrane, respectively [9]. In response to a
death stimulus, the BH3-only proteins are activated transcription-
ally and/or by post-translational modifications and cause the
oligomerization of BAX and BAK resulting in mitochondrial outer
membrane permeabilization (MOMP). This allows proteins that
normally reside in the intermembrane space, such as cytochrome c,
to enter the cytosol [10,11]. When cytochrome c is released into the
cytosol, it forms a complex with APAF-1 and pro-caspase-9 in an
ATP-dependent manner resulting in the formation of the apopto-
some which in turn activates downstream executioner caspases
resulting in apoptosis [12,13].
BH3-only proteins and the anti-apoptotic proteins are upstream
regulators of BAX and BAK activation yet the exact mechanism by
which these proteins initiate apoptosis is not completely understood.
Currently, there are two models that describe how these proteins
mediate BAX and BAK activity, the indirect activation model and
thedirectactivationmodel.Theindirectactivationmodelpostulates
that in healthy cells, anti-apoptotic proteins associate with BAX and
BAK and repress their activity [14]. In response to a death stimulus,
BH3-only proteins interact with the anti-apoptotic proteins,
displacing them from BAX and BAK resulting in MOMP. This
model assumes that BAX and BAK are kept in check by anti-
apoptotic proteins. The direct activation model divides the BH3-
only proteins into ‘‘activators’’ (BID, BIM and PUMA) and
‘‘sensitizers’’ (all other BH3-only proteins). This model proposes
that the anti-apoptotic family members prevent cell death by
disrupting signaling upstream of BAX and BAK by binding to the
‘‘activator’’ BH3-only proteins and negating their function [15]. In
response to a death stimulus, the ‘‘sensitizer’’ BH3-only proteins
bind to the anti-apoptotic proteins, releasing the ‘‘activators’’ and
allowing them to induce apoptosis by directly activating BAX and
BAK. Despite suggesting different mechanisms of action, both
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7059models agree that the anti-apoptotic BCL-2 proteins need to be
negated for BAX and BAK mediated MOMP.
Previous studies have demonstrated that the loss of BAX and
BAK, prevents NO induction of cell death [16–19]. As mentioned,
BAX and BAK activation is regulated by BH3-only proteins yet it
is not known which BH3-only proteins are involved in NO-
induced cell death. Furthermore, the signaling pathways that are
initiated by NO to activate BAX/BAK-induced cell death are also
unknown. In the present study, we investigated which signaling
pathways and BH3-only proteins cause the negation of anti-
apoptotic BCL-2 proteins to cause NO-induced cell death.
Results
Nitric oxide-induced cell death requires the intrinsic
apoptotic proteins, BAX, BAK and Caspase-9, and causes
release of cytochrome c from the mitochondria
To investigate the mechanism by which long-term exposure to
NO cause’s cell death we used the slow-releasing NO donor,
diethylenetriamine (DETA)-NO. DETA-NO mimic’s steady state
production of NO at concentrations observed with activated
macrophages [24,25]. BAX, BAK and Caspase-9 are integral
members of the intrinsic apoptotic pathway. To determine if NO
induces cell death in a BAX/BAK-dependent manner, wild type
and Bax
2/2/Bak
2/2 MEFs were exposed to DETA-NO for 24
and 48 hours. Cell death was measured by LDH release, a pan
marker of plasma membrane disruption. Wild type MEFs show a
concentration dependent increase in cell death in response to
DETA-NO whereas, Bax
2/2/Bak
2/2 MEFs are completely
protected at all concentrations and time points (Figure 1A/B).
To confirm that NO induces BAX/BAK-dependent apoptosis,
wild type and Bax
2/2/Bak
2/2 MEFs were treated with DETA-
NO and stained with annexin V. Wild type MEFs show increased
apoptosis in response to NO, whereas Bax
2/2/Bak
2/2 MEFs are
completely protected (Figure 1C/D). To determine if BAX and
BAK are activated in response to NO, wild type MEFs were
treated with DETA-NO for 24 hours and BAX and BAK
activation was determined using antibodies that specifically
recognize the activated form of these proteins [20,23]. Indeed,
BAX and BAK are activated in response to NO treatment
indicating that both of these proteins regulate NO-mediated apo-
ptosis (Figure 1E/F). Bax or Bak reconstitution sensitized Bax
2/2/
Bak
2/2 MEFs to NO-induced apoptosis indicating that these
proteins, individually, are involved in this pathway (Figure 2A–C).
Cytochrome c release and caspase-9 activation occur downstream
of BAX and BAK activation and are required for BAX/BAK-
dependent apoptosis. Cytochrome c is released in wild-type MEFs
exposed to DETA-NO (Figure 3A). Additionally, Caspase-9
2/2
MEFs treated with DETA-NO for 24 and 48 hours did not
undergo cell death (Figure 3B, C).
The individual loss of the BH3-only proteins, BID, BIM,
PUMA, BAD or NOXA, is not sufficient to protect against
nitric oxide-induced cell death
The best known upstream regulators of BAX and BAK are the
BH3-only proteins. Thus, we wanted to identify which BH3-only
proteins activate BAX and BAK during NO-induced cell death.
To test the role of individual BH3-only proteins during NO






2/2 MEFs were treated with DETA-NO for 24 and 48 hours
and cell death was measured by LDH release. Bid
2/2 MEFs were
slightly protected 24 hours after treatment compared to wild type
controls but this protection was not sustained to 48 hours,
indicating that the loss of Bid is not sufficient to protect cells from





2/2 MEFs all died at rates similar to wild type controls,
suggesting that these proteins are not individually required for
NO-induced cell death (Figure 4B–E).
The combined loss of direct activator BH3-only proteins
does not protect cells from nitric oxide-induced cell
death
The anti-apoptotic BCL-2 proteins need to be negated by the
BH3-only proteins; either to release the inhibition on BAX and
BAK or to release ‘‘activator’’ BH3-only proteins (BIM, BID,
PUMA) which subsequently bind and activate BAX and BAK
[14,15]. Since the individual loss of the BH3-only proteins, BIM,
BID, PUMA, BAD and NOXA did not prevent NO-induced cell
death we wanted to examine if the combined loss of BH3-only
proteins, namely the ‘‘activator’’ BH3-only proteins, protects cells
from NO-induced apoptosis, wild type and Bim
2/2/Puma
2/2
MEFs were treated with DETA-NO for 24 and 48 hours and cell
death was measured by LDH release. Bim
2/2/Puma
2/2 MEFs
died at rates similar to wild type controls (Figure 5A). We reduced
Bid expression in Bim
2/2/Puma
2/2 MEFs using shRNA
(Figure 5B). Bim
2/2/Puma
2/2 MEFs expressing shRNA targeted
against Bid also died at rates similar to controls (Figure 5C). These
results suggest that the direct activator proteins, BIM, BID and
PUMA do not regulate NO-dependent BAX/BAK activation.
The ASK1-JNK1 axis is a key regulator in nitric oxide-
induced cell death
NO has been shown to modulate JNK activity [26,27] and JNK
has been shown to be an upstream regulator of BAX and BAK
[28–30]. To determine if NO activates JNK upstream of BAX and
BAK, we treated Bax
2/2/Bak
2/2 MEFs with DETA-NO and
assessed JNK activity by measuring expression of phoshpo-cJun, a
downstream target of JNK. NO activates JNK as early as 8 hours
after exposure to NO, and this activation was sustained to
24 hours (Figure 6A). Additionally, this data shows that JNK
activation in response to NO occurs upstream of BAX and BAK.
The JNK inhibitor SP600125 effectively inhibits NO-dependent
JNK activity for up to 24 hours (Figure 6B), and chemical
inhibition of JNK protects wild type MEFs from NO-induced cell
death (Figure 6C). Three genes encode the JNK protein kinases.
Jnk1 and Jnk2 are ubiquitously expressed, whereas Jnk3 is
expressed primarily in the brain, heart and testis [31]. JNK1 has
been proposed as the major JNK isoform that regulates cell death
[21]. Indeed, Jnk1
2/2 MEFs were markedly protected against
NO-induced cell death compared with Jnk2
2/2 MEFs and wild
type MEFs (Figure 6D). Interestingly, other MAPK family
members such as ERK and p38 were activated by NO
(Figure 7A and C) but were not required for cell death
(Figures 7B and E). The apoptosis signal-regulating kinase 1
(ASK1) is regulated by NO [32]. Previous studies indicate that
ASK1 is a MAPKKK that activates both JNK and p38 pathways
[33]. To determine if ASK1 activates JNK in response to NO,
Ask1
2/2 MEFs were treated with DETA-NO and phospho-JNK
expression was determined by Western analysis. JNK is not
phosphorylated in Ask1
2/2 MEFs after treatment with DETA-
NO, but is phosphorylated in Bax
2/2/Bak
2/2 MEFs (Figure 8A).
Furthermore, Ask1
2/2 MEFs treated with DETA-NO are
protected from NO-induced cell death as measured by LDH
release (Figure 8B). These results indicate that NO activates ASK1
which subsequently initiates JNK1-dependent cell death.
NO-Induced Cell Death
PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7059Nitric oxide induces ASK1-JNK1-dependent degradation
of MCL-1
JNK has been reported to inactivate the anti-apoptotic BCL-2
protein, MCL-1. We examined whether the ASK1-JNK1 axis
negates MCL-1 as a mechanism for NO-dependent cell death. A
widely accepted mechanism for MCL-1 negation following a death
stimulus involves proteosomal degradation of the MCL-1 protein
[34,35]. To determine if MCL-1 turnover is affected by NO
Figure 1. Nitric oxide induces apoptosis through the intrinsic apoptotic pathway. Wild type and Bax
2/2/Bak
2/2 MEFs were treated with 0,
100, 200 and 400 mM DETA-NO for 24 (A/C) and 48 (B/D) hours. Cell death was measured by percent LDH release (A/B). Apoptosis was measured by
percent Annexin V and propidium iodide staining (C/D). BAX and BAK activation was determined in wild type MEFs treated with (red) and without
(black) DETA-NO (400 mM) for 24 hours (E/F).
doi:10.1371/journal.pone.0007059.g001
NO-Induced Cell Death
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2/2/Bak
2/2
MEFs with DETA-NO and measured MCL-1 protein expression.
NO induced a decrease in MCL-1 protein levels upstream of BAX
and BAK (Figure 9A). To determine if MCL-1 turnover is the result
of proteosomal degradation, Bax
2/2/Bak
2/2 MEFs were treated
withDETA-NO inthepresence ofa the proteosomalinhibitor MG-
132. The NO-induced decrease in MCL-1 protein was inhibited in
cells treated with the proteosomal inhibitor (Figure 9B). To
determine if ASK1 or JNK1 mediates NO-induced MCL-1
degradation, Jnk1
2/2 MEFs or Ask1
2/2 MEFs were exposed to
DETA-NO. MCL-1 protein levels remained stable in Jnk1
2/2
MEFsandinAsk1
2/2 MEFsexposedto DETA-NO (Figure9Cand
9D). These results indicate that NO activates ASK1-JNK1 axis to
initiate the degradation of MCL-1.
Nitric oxide-induced MCL-1 degradation occurs through
a non-canonical pathway
The canonical pathway for MCL-1 degradation involves the
activation of the BH3-only protein NOXA, which binds MCL-1
and induces its degradation by the proteosome [14,36]. To
examine NOXA’s involvement in NO-dependent MCL-1 degra-
dation, Noxa
2/2 MEFs were treated with DETA-NO and MCL-1
protein expression was assessed. MCL-1 is degraded in the
absence of NOXA following NO treatment (Figure 10A). The E3
ligase, Mule, polyubiquitinates MCL-1 at five lysine residues (5,
40, 136, 194 and 197) to initiate proteosomal degradation [37].
Mutation of these five critical residues markedly increases the half-
life of MCL-1 (Figure 10B). To determine if these five residues are
required for NO-induced MCL-1 degradation, MEFs expressing
MCL-1 with mutations at all five of these critical residues (MCL-1
5K mutant MEFs) were exposed to DETA-NO. Surprisingly, the
5K mutant MCL-1 is degraded following treatment with NO
(Figure 10C). Additionally, MEFs expressing the 5K mutant die in
response to NO (Figure 10D). These data indicate that NO
induces degradation of MCL-1 through a non-canonical pathway.
Nitric oxide-induced cell death is not initiated by ROS
generation or peroxynitrite formation
A mechanism by which NO could activate the ASK1-JNK1 axis
to initiate BAX/BAK-dependent cell death is through ROS
generation. ASK1 and JNK1 are both known to be activated by
oxidative stress [38–40]. NO can increase mitochondrial oxidative
stress by inhibiting cytochrome c oxidase [41]. This could cause
the upstream electron transport chain to exist in a more reduced
state and enhance superoxide production [5]. To functionally test
whether NO inhibits respiration, we cultured Bax
2/2/Bak
2/2
MEFs in media containing galactose instead of glucose. Supple-
menting glucose for galactose reduces glycolysis and forces cells to
rely heavily on oxidative phosphorylation for ATP generation and
survival. Bax
2/2/Bak
2/2 MEFs are protected against DETA-NO
in media containing glucose (Figure 1A–D). Thus, if NO inhibits
mitochondrial respiration, Bax
2/2/Bak
2/2 MEFs cultured in
galactose would die since they cannot utilize glycolysis to generate
ATP for survival. Indeed, NO, like the complex I inhibitor
rotenone, induces cell death in Bax
2/2/Bak
2/2 MEFs when
cultured in galactose (Figure 11A). These results indicate that NO
Figure 2. BAX and BAK mediate nitric oxide-indeced cell death. Bax
2/2/Bak
2/2 MEFs were infected with either Bax, Bak or GFP as a control.
BAX and BAK expression was verified by Western analysis (A,B). Bax
2/2/Bak
2/2 MEFs expressing GFP, BAK or BAX were treated with 0, 100, 200 and
400 mM DETA-NO for 48 hours and cell death was measured by LDH release (C).
doi:10.1371/journal.pone.0007059.g002
NO-Induced Cell Death
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is a SOD/catalase mimetic and reduces ROS, did not protect cells
from DETA-NO (Figure 11B). PEITC depletes glutathione and
generates an increase in intracellular ROS [42]. EUK-134
protected MEFs from PEITC-induced cell death (Figure 11B).
Additionally, wild type MEFs pre-treated with the peroxynitrite
scavengers, uric acid or ebselen, also died at rates similar to
controls (Figure 11C and 11D). By contrast, the NO scavenger
PTIO decreased DETA-NO-induced cell death (Figure 11E).
These results indicate that NO-induced activation of BAX/BAK-
dependent cell death is independent of peroxynitrite formation
and ROS generation.
Discussion
Previous studies have demonstrated that the overexpression of
anti-apoptotic BCL-2 family members prevents NO-induced cell
death, suggesting that the NO induces cell death through the
activation of the intrinsic apoptotic pathway [16]. BAX and BAK
are integral members of the intrinsic pathway. Activation of these
proteins results in cytochrome c release from the mitochondria
and activation of Caspase-9. Our data show that BAX and BAK
are activated by NO and that cytochrome c is released from the
mitochondria. The combined loss of BAX and BAK, or the
individual loss of Caspase-9, completely prevents NO-induced cell
death indicating that these proteins are required for this pathway.
Activation of BAX and BAK is dependent on interactions
between anti-apoptotic and pro-apoptotic BCL-2 proteins. There
are currently two models that attempt to explain how these
interactions orchestrate BAX and BAK activation. Despite
differences in these models, both agree that BH3-only proteins
are major upstream regulators of BAX and BAK activity. Both
models agree that BIM, BID and PUMA are potent activators of
apoptosis but through distinct mechanisms. The indirect activation
model views these proteins as potent because they are able to bind
and inhibit all of the anti-apoptotic BCL-2 proteins, whereas other
BH3-only proteins have selective partners [43]. In this model, the
negation of BCL-2 proteins is sufficient to induce BAX and BAK
activation. The indirect activation model proposes that anti-
apoptotic BCL-2 members negate the activity of BAX or BAK in
healthy cells. In response to a death stimulus, BH3-only proteins
such as BIM bind to the anti-apoptotics and displace them from
BAX and BAK. By contrast, the direct activation model proposes
that BIM, BID and PUMA are potent because they can directly
activate BAX and BAK [15,44].
In the present study, we find that cells collectively deficient in
Bim and Puma with reduced Bid expression still die in response to
NO. We speculate that a BH3-only protein other than BIM, BID,
Figure 3. Cytochrome c is released and caspase-9 is required for nitric oxide-induced cell death. Cytochrome c release was measured in
wild type MEFs treated with 400 mM DETA-NO for 24 hours (A). b-actin was used as a loading control. Wild type and Caspase-9
2/2 MEFs were treated
with 0, 100, 200 and 400 mM DETA-NO for 24 (B) and 48 hours (C) and cell death was measured by LDH release.
doi:10.1371/journal.pone.0007059.g003
NO-Induced Cell Death
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NO or that NO promotes binding of multiple proteins to anti-
apoptotic BCL-2 members, negating their activity.
A major mechanism for negating anti-apoptotic BCL-2 protein is
through degradation. For example, MCL-1 is degraded in response
to a variety of death stimuli including DNA damage, cytokine
withdrawal, and anoxia [20,34,35,45,46]. NO induces proteosomal
degradation of MCL-1 even in the absence of BAX and BAK,
suggesting this is an early event in the pathway. Previous studies
indicate that the BH3-only protein NOXA stimulates MCL-1
degradation upon exposure to a death stimulus. Furthermore,
MCL-1 protein is ubiquitinated at five critical lysine residues that
are required for degradation. Surprisingly, NO causes MCL-1
degradation in the absence of NOXA, and a mutant form of MCL-
1, that can not be ubiquitinated at the five critical lysine residues, is
also degraded. Collectively, these data indicate that MCL-1 is
degraded by a non-canonical mechanism that does not involve
NOXA or ubiquitinylation of MCL-1 at five specific lysine residues.
Figure 4. The individual loss of the BH3-only proteins BID, BIM, PUMA, BAD and NOXA does not protect against nitric oxide-




2/2 (D) and Noxa
2/2 (E) MEFs were treated with 0 and 400 mM DETA-NO for
24 and 48 hours. Percent cell death was measured by LDH release.
doi:10.1371/journal.pone.0007059.g004
NO-Induced Cell Death
PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e7059The signaling pathways that negate anti-apoptotic BCL-2
proteins to allow BAX and BAK activation are not fully
understood. The JNK and p38 MAPK family members have
been implicated as death kinases. Specifically, JNK1 but not
JNK2, is implicated in the induction of cell death [21]. JNK can
phosphorylate BIM or BID to induce BAX/BAK dependent cell
death [29,47]. JNK can also phosphorylate and inactivate MCL-1
[48,49]. Previous studies have shown that NO can activate JNK
and/or p38 MAPK, and that activation of these signaling
pathways can induce cell death [50]. Our data indicate that
p38a and JNK2 are dispensable in NO induced cell death, but
Jnk1 null cells are markedly protected from NO-induced cell
death. Furthermore, NO does not induce MCL-1 protein
degradation in the absence of Jnk1. These results indicate that in
the absence of Jnk1, cell survival is due to the maintenance of
MCL-1.
ASK1 activates the JNK signaling pathway under conditions of
high oxidative stress. ASK1 is associated with the reduction/
oxidation (redox)-regulatory protein, thioredoxin (Trx) [51]. ROS
oxidize cysteine residues of the Trx protein causing it to dissociate
from ASK1 resulting in its activation through autophosphoryla-
tion. Indeed, MCL-1 protein levels were maintained in Ask1
deficient cells and these cells did not undergo cell death. However,
we found no evidence that the NO-induced cell death pathway
was dependent on oxidative stress. This was surprising since NO
can inhibit the mitochondrial respiratory chain and increase
oxidative stress [41]. In our experiments, NO was able to block
oxidative phosphorylation. We speculate that NO might cause
direct S-nitrosylation of the cysteine residues of Trx thereby
liberating ASK1 to induce cell death.
In summary, our data reveal that NO negates anti-apoptotic
BCL-2 family members, in part through the activation of the
Figure 5. The combined loss of direct activator proteins does not protect cells from nitric oxide-induced cell death. Wild type and
Bim
2/2/Puma
2/2 MEFs were treated with 0 and 400 mM DETA-NO for 24 and 48 hours and cell death was measured by percent LDH release (A). BID
protein expression was assessed in Bim
2/2/Puma
2/2 MEFs stably expressing scrambled shRNA or shRNA targeted against Bid (B). Bim
2/2/Puma
2/2
MEFs stably expressing scrambled shRNA or shRNA targeted against Bid were treated with 0, 100, 200 and 400 mM DETA-NO at the indicated
concentrations for 48 hours and cell death was measured by percent LDH release (C).
doi:10.1371/journal.pone.0007059.g005
NO-Induced Cell Death
PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7059ASK1-JNK1 pathway, which leads to BAX/BAK-dependent cell
death. These findings have implications for the role of inflamma-
tion in cancer progression. Recent data indicate that inflammation
can exacerbate cancer progression. MCL-1 and BCL-XL are up-
regulated in many types of cancers. Activated macrophages, which
release high levels of NO during inflammation, are capable of
destroying neoplastic cells. However, if BCL-2 proteins are
upregulated in tumor cell this would prevent NO-dependent cell
death resulting tumor progression. This would further select tumor
cells that have elevated levels of anti-apoptotic BCL-2 proteins and
make them resistant to chemotherapy or radiotherapy.
Methods















and their wild type controls were cultured as previously reported
[20–22]. Bim
2/2/Puma
2/2 MEFs and their wild type controls and
PT67 were cultured in Dulbecco’s modified essential medium
(DMEM) with 4.5 g/liter glucose, L-glutamine, and sodium
pyruvate (Invitrogen). Media was supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (Invitrogen), 100 U/ml
penicillin/100 mg/ml streptomycin (P/S) (Cellgro), 20 mM
HEPES (Cellgro) and 1X NEAA (Invitrogen). MCL-1 5K mutant
MEFs and 293FT were cultured in the above media supplemented
with G418. Bim
2/2/Puma
2/2 MEFs were transformed with
dominant negative p53. Galactose media was prepared as follows,
DMEM without glucose (GIBCO), 10% FBS, 20 mM galactose,
P/S, HEPES.
Measurement of cell death and apoptosis
Cell death was measured using the Cytotoxicity Detection Kit
(Roche Applied Science) according to manufacturer’s protocol.
The kit is a colormetric assay based on the measurement of lactate
dehydrogenase (LDH) released by dead cells. Percent cell death is
determined by the amount of LDH measured in the medium
divided by the amount of LDH after addition of 1% Triton-X 100,
which kills all the cells.
Apoptosis was measured using the Annexin V-FITC Apoptosis
Detection Kit (BD Pharmingen) according to manufacturer’s
Figure 6. Nitric oxide initiates cell death through the ASK1-JNK1 pathway. Phospho-JNK and phospho-cJun were measured in Bax
2/2/
Bak
2/2 MEFs treated with 400 mM DETA-NO at 0, 8, 16 and 24 hours (A). Bax
2/2/Bak
2/2 MEFs were pretreated with 40 mM SP600125 for 30 minutes
followed by 400 mM DETA-NO for 8, 16 and 24 hours and phospho-c-Jun was measured (B). Wild type MEFs were pretreated with 40 mM SP600125 for
30 minutes followed by 0, 100, 200 and 400 mM DETA-NO for 24 hours. Percent cell death was measured by LDH release (C). Percent LDH release was
measured in wild type, Jnk1
2/2 and Jnk2
2/2 MEFs treated with 0, 100, 200 and 400 mM DETA-NO (D).
doi:10.1371/journal.pone.0007059.g006
NO-Induced Cell Death
PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e7059Figure 7. p38 and ERK are activated by NO, but do not mediate NO-induced cell death. Phospho-p38 was measured to assess p38 activity
in Bax
2/2/Bak
2/2 MEFs treated with 400 mM DETA-NO for 8, 16 and 24 hours (A). Percent LDH release was measured in wild type and p38
2/2 MEFs
treated with 0, 100, 200 and 400 mM DETA-NO for 24 hours (B). Phospho-ERK was measured to assess ERK activity in Bax
2/2/Bak
2/2 MEFs treated
with 400 mM DETA-NO for 8, 16 and 24 hours (C). Phospho-ERK was measured in Bax
2/2/Bak
2/2 MEFs pretreated with 10 mM of the ERK inhibitor




PLoS ONE | www.plosone.org 9 September 2009 | Volume 4 | Issue 9 | e7059protocol. After treatment, cells were washed twice with cold PBS
and resuspended in 1X binding buffer at a concentration of 1610
6
cells per milliliter. Annexin-V-FITC (excitation: 488 nm, emission:
525) was added to the cells and analyzed by flow cytometry.
Measurement of BAX and BAK activation
BAX and BAK activation was determined as previously
published [23]. Briefly, adherent and non-adherent cells were
collected in 1X Cell Dissociation Solution Non-enzymatic (Sigma).
Cells were fixed in 0.25% paraformaldehyde for 1 minute then
washed with phosphate-buffered saline (PBS). Cells were incubat-
ed with anti-Bax antibody (BD Pharmingen clone 6A7) or anti-Bak
antibody (Calbiochem) for 30 minutes at a concentration of 1:50 in
PBS containing 100 mg/mL digitonin (Sigma). Cells were washed
with PBS then incubated in FITC-conjugated rat anti-mouse
immunoglobulin (BD Pharmingen clone A85-1) at a concentration
of 1:50 in PBS containing 100 mg/mL digitonin. Cells were
washed in PBS and analyzed by flow cytometry.
Measurement of cytochrome c release
Cells were collected in mitochondrial isolation buffer (250 mM
Sucrose, 10 mM Tris-HClpH 7.4,0.1 mM ethyleneglycoltetraacetic
acid (EGTA)) and homongenized on ice using a Dounce homo-
genizer. Cells were then expelled through a 27-guage needle 10 times.
Samples were centrifuged at 1000rpm for 10 minutes. Subsequently,
the supernatants were centrifuged at 15,000rpm for 20 minutes to
pellet the mitochondria. The mitochondrial pellet was solubilized
in mitochondrial isolation buffer containing 10X lysis buffer.




treated with 0 or 400 mM DETA-NO (A). Percent LDH release was measured in wild type and Ask1
2/2 MEFs treated with 0, 100, 200 and 400 mM DETA-
NO (B).
doi:10.1371/journal.pone.0007059.g008
Figure 9. MCL-1 is degraded in response to nitric oxide treatment and is dependent on the ASK1/JNK1 pathway. MCL-1 protein
expression was measured in Bax
2/2/Bak
2/2 MEFs treated with 400 mM DETA-NO for 0, 8, 16 and 24 hours (A). MCL-1 degradation was measured in
Bax
2/2/Bak
2/2 MEFs pre-treated with or without 20 mM MG132 followed by 0 or 400 mM DETA-NO for 24 hours (B). MCL-1 protein expression was
measured in Jnk1
2/2 (C), Ask1
2/2 (D) MEFs treated with 400 mM DETA-NO for the indicated time points.
doi:10.1371/journal.pone.0007059.g009
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Phospho-JNK, JNK, phospho-cJun and cJun antibodies were
ordered from Cell Signaling. Additionally, antibodies used for
Western blot analysis include: Mcl-1 (Rockland), Bid (R&D
Systems), Bim (BD Pharmingen), Cytochrome c (MitoSciences),
b-actin (Sigma), Tubulin (Sigma), and GAPDH (Santa Cruz).
Briefly, cell lysates were collected in 1X Cell Lysis Buffer (20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM
EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM beta-
glycerophosphate, 1 mM Na3VO4,1 mg/ml leupeptin) (Cell
Signaling) and amount of total protein was determined by
Bradford Assay. Lysates were separated on a 10% Tris-HCl
Polyacrilimide Gel (BioRad) and transferred to a nitrocellulose
membrane. Membranes were incubated in blocking buffer (1X
TBS, 0.1% Tween-20 with 5% nonfat dry milk) for 1 hour
followed by primary antibody incubation at 4uC overnight. The
following day, membranes were washed and then incubated in
HRP linked anti-mouse or anti-rabbit (Cell Signaling) for 1 hour.
SuperSignal chemiluminescent substrate (Pierce) was used to
detect protein levels.
Lentiviral production and generation of stable cell lines
The pLKO.1 vector was used to express shRNA targeting Bid.
Constructs were ordered from Open Biosystems with the following




non-silencing shRNA was ordered from Addgene (plasmid
1864), 59 cctaaggttaagtcgccctcgctctagcgagggcgacttaaccttagg 39.
Stable cell lines were generated using lentiviral infection using
the 293FT packaging cell line and puromycin selection.
Figure 10. Nitric oxide-induced MCL-1 degradation occurs through a non-canonical pathway. MCL-1 protein expression was measured in
Noxa
2/2 MEFs treated with 400 mM DETA-NO for 0, 8, 16 and 24 hours. Wild type and MCL-1 5K mutant MEFs were exposed to normoxia for 14 hours
and subsequently treated with 5 mg/mL cycloheximide to inhibit protein translation. Cell lysates were collected at 30 minute intervals for 2 hours and
MCL-1 expression was analyzed by Western blot. Tubulin served as a loading control (B). MCL-1 5K mutant MEFs were treated with 400 mM DETA-NO
for 0, 8, 16 and 24 hours (C). Wild type and MCL-1 5K mutant MEFs were treated with 0 and 400 mM DETA-NO for 24 and 48 hours. Cell death was
measured by percent LDH release (D).
doi:10.1371/journal.pone.0007059.g010
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2/2/Bak
2/2 MEFs adapted to glucose or galactose
were treated with 400 mM DETA-NO or 10 mM rotenone for 48 hours and cell death was measured by percent LDH release (A). Wild type MEFs were
pre-treated with the ROS inhibitor EUK-134 (20 mM) followed by 0, 100, 200 and 400 mM DETA-NO for 24 hours and cell death was measured by LDH
release (B). PEITC is known to generate endogenous ROS and was used as a positive control. Wild type MEFs were pre-treated with the peroxynitrite
scavengers, uric acid (1 mM) and ebselen (10 mM) followed by 0, 100, 200 and 400 mM DETA-NO for 24 hours and cell death was measured by percent
LDH release (C and D). Wild type MEFs were pre-treated with the nitric oxide scavenger PTIO (1 mM) followed by 0, 100, 200 and 400 mM DETA-NO for
24 hours and cell death was measured by percent LDH release (E).
doi:10.1371/journal.pone.0007059.g011
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The GatewayH Lentiviral Expression Kit (Invitrogen) was used
to overexpress FLAGH tagged BCL-XL. Flag-BCL-XL was cloned
into pDONR221 by BP recombination and then into pLenti6/V5-
DEST by LR recombination. Stable cell lines were generated by
transfecting the 293FT packaging cell line.
MCL-1 5K mutant construct generation and expression
The pLNCX vector containing human MCL-1 was a kind gift
from Dr. Aly Karsan. The MCL-1 5K mutant was made using
Site-Directed Mutagenesis (Stratagene) following manufacturer’s
instructions. Lysines at positions 5, 40, 136, 194 and 197 of MCL-
1 were changed to arginines using the following primers: K5R,
forward 59 ggcaatgtttggcctcagaagaaacgcggtaatcgg 39 and reverse
59 ccgattaccgcgtttcttctgaggccaaacattgcc 39, K40R: forward 59 cga-
cttttggctacggagagggaggcctcg 39 and reverse 59 cgaggcctccctctccg-
tagccaaaagtcg 39,
K136R: forward 59 cggagcctctcgggaggcggccgg 39 and reverse -
59 ccggccgcctcccgagaggctccg 39, K194/197R forward 59 ggcc-
accggcgccagggacacagagccaatg 39 and reverse 59 cattggctc-
tgtgtccctggcgccggtggcc 39. Mutations were confirmed by DNA
sequencing. Stable cell lines were generated by transfecting the
PT67 packaging cell line using Mirus Trans IT Transfection
reagent (Mirus Bio Corporation) according to the manufacturer’s
protocol. Cell lines were selected with G418 (Sigma).
Other Reagents
The following reagents were used: (Z)-1-[N-(2-Aminoethyl)-N-
(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NO,
AlexisH Biochemicals), Z-Leu-Leu-Leu-aldehyde (MG-132,
20 mM, Calbiochem), SP600125 (40 mM, A.G. Scientific, Inc.),
Ebselen (10 mM, A.G. Scientific), chloro[[2,2’-[1,2-ethanediylbis
[(nitrilo-.kappa.N)methylidyne]]
bis[6-methoxyphenolato-.kappa.O]]]-manganese (EUK-134,
20 mM, Cayman Chemical), uric acid (1 mM, MP Biochemicals),
2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO,
1 mM, Sigma), phenethyl isothiocyanate (PEITC, 20 mM, Sigma),
UO126 (10 mM, Sigma), and rotenone (10 mM, Sigma).
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